Westchester Capital Management (New York)’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-147,664
Closed -$7.63M 596
2022
Q3
$7.63M Buy
+147,664
New +$6.1M 0.21% 72

Other funds holding CCXI

Westchester Capital Management (New York)'s CCXI Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 147,664 shares — an estimated $7.63M sold.

Westchester Capital Management (New York) first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $7.63M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Westchester Capital Management (New York) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 147,664 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7.63M.
  • Westchester Capital Management (New York) first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s ChemoCentryx, Inc. position peaked at $7.63M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.